Lloyd’s 2022 medical start-up syndicate seeks ILS, Names capital

The former QBE underwriting team behind the 1.1.22 Lloyd’s medical start-up syndicate are expected to attract backing from both ILS funds and third-party Names’ capital, The Insurer can reveal.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com

      Lloyd's